#ACTG

StockTitan

@stocktitan.net

3 days ago

Acacia Research Corporation Reports Fourth Quarter and Year End 2025 Financial Results Acacia Research (Nasdaq: ACTG) reported record 2025 revenue of $285.2 million, up 133% YoY, driven by full-year contributions from Manufacturing and Revolution energy assets and higher IP revenue. Fourth-quarter revenue was $50.1 million; GAAP net income was $3.4 million and cash, equivalents and loans totaled $339.6 million ($3.52 per share) at year end.

#ACTG Acacia Research Corporation Reports Fourth Quarter and Year End 2025 Financial Results

www.stocktitan.net/news/ACTG/acacia-researc...

StockTitan

@stocktitan.net

7 months ago

Acacia Research Corporation Reports Second Quarter 2025 Financial Results Acacia Research (NASDAQ:ACTG) reported Q2 2025 financial results with total revenue of $51.2 million, up 98% year-over-year, primarily driven by $29.0 million from Manufacturing Operations. The company posted a GAAP Net Loss of ($3.3) million, or ($0.03) per share, and Adjusted Net Loss of ($5.9) million, or ($0.06) per share.The company maintained a strong financial position with $338.2 million in cash, cash equivalents, and equity securities ($3.51 per share). Total Company Adjusted EBITDA was $1.9 million, while Operated Segment Adjusted EBITDA reached $6.8 million. Acacia also announced a new partnership with Unchained and Build Asset Management for a Bitcoin-backed commercial loan strategy.The company's consolidated total indebtedness stood at $104.4 million, consisting of non-recourse debt at Benchmark ($58.0M) and Deflecto ($46.4M). Book value per share was $5.99 as of June 30, 2025.

#ACTG Acacia Research Corporation Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/ACTG/acacia-researc...

@colinbbegg.bsky.social

7 months ago

Yu Zheng and colleagues explore the heterogeneity of treatment effect in an HIV clinical trial with a view to fulfilling the promise of precision medicine. #clinicaltrials #precisionmedicine #publichealth #ACTG #HIV

Small Cap Strategist

@smcapstrategist.bsky.social

10 months ago

Small-cap stocks with strong volume gains, Thu May 8th - #DHX #EBS #CRVS #BMBL #FSLY #GFR #ACTG #MAGN #VCSA #QBTS #ZVIA #DAVE #ECPG #GRPN #ZKIN #SEZL #HDSN #JRSH #MRTN #NTHI #OM #RDVT - More: crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

10 months ago

Acacia Research Corporation Reports First Quarter 2025 Financial Results Acacia Research Corporation (NASDAQ: ACTG) reported strong Q1 2025 financial results, with total revenue reaching $124.4 million, a 412% increase from $24.3 million in Q1 2024. The company posted GAAP Net Income of $24.3 million ($0.25 EPS) and Adjusted Net Income of $33.1 million ($0.34 EPS).The revenue growth was primarily driven by $69.9 million from Intellectual Property operations, $18.3 million from Energy Operations, and $28.5 million from Manufacturing Operations. Total Company Adjusted EBITDA was $50.7 million, while Operated Segment Adjusted EBITDA reached $54.7 million. The company's current cash position, including post-quarter proceeds, stands at approximately $338.2 million ($3.52 per share), providing substantial resources for future growth opportunities.

#ACTG Acacia Research Corporation Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/ACTG/acacia-researc...

Alex Armenta (she/her)

@bioethiquemx.bsky.social

11 months ago

"the AIDS Clinical Trials Group (ACTG)—the largest funder of #HIV research worldwide—has been delayed. #ACTG chair Joseph Eron, told STAT that enrollment for all studies has been paused.

Funding for the HIV Prevention Trials Network and the HIV Vaccine Trials Network has also been suspended"

Alex Armenta (she/her)

@bioethiquemx.bsky.social

11 months ago

@liz @docdelrio.bsky.social this is bad news for multicenter clinical trials and reseach equity on HIV research.

#ACTG enables respresentation of communities in different settings/countries and has great standards of community engagement through local and global community advysory boards.

Kristina Brooks

@kmb-pharmd.bsky.social

1 year ago

Tecovirimat is safe but ineffective as treatment for clade II mpox NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions.

Proud to be part of the #ACTG A5418 study team! This is why we need these studies - we can’t rely on animal data alone and people deserve safe and effective #mpox treatment. Stay tuned for more on the PK and PK/PD! @cupharmacy.bsky.social @cuanschutz.bsky.social #IDSky www.nih.gov/news-events/...

StockTitan

@stocktitan.net

1 year ago

Acacia Research Transforms with $248M Acquisitions, Reports $122M Annual Revenue Acacia Research delivers $48.8M Q4 revenue across energy, manufacturing, and industrial operations. Strategic acquisitions of Revolution and Deflecto strengthen market position.

#ACTG Acacia Research Corporation Reports Fourth Quarter and Year End 2024 Financial Results

www.stocktitan.net/news/ACTG/acacia-researc...

StockTitan

@stocktitan.net

1 year ago

When Will Acacia Research Reveal Its 2024 Performance? Key Date for Investors Acacia Research will release Q4 and 2024 results before market open on March 13, with an 8:00 a.m. ET conference call for investors to discuss performance.

#ACTG Acacia Research to Release Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

www.stocktitan.net/news/ACTG/acacia-researc...

Romi Burks

@profromi.bsky.social

8 years ago

Genome workshop enlightening - I've downloaded 2 cacao genomes & compared human & Apple Snail mitochondria #somuchdata #actg